March 8, 2024
1 min read
As key members of the multidisciplinary care team, thoracic surgeons play a pivotal role in the patient journey for resectable Non-Small Cell Lung Cancer. This patient journey map, suitable for both surgeons and patients, outlines the stages of treatment of resectable NSCLC from diagnosis and staging, to resection, referral to a medical oncologist, and surveillance. This includes consideration of biomarker testing during the diagnostic biopsy and resection stages, and the potential benefit of perioperative and adjuvant therapies.
Click the image below to view or download the full document.
Image
Additional Resources
Webinars
- Biomarker Testing and Neoadjuvant Immunotherapy for Resectable NSCLC
- Sublobar Resection Versus Lobectomy for Early-Stage Lung Cancer: A Debate
Video